Even though our data demonstrate the prognostic and predictive value of SLC1A5 in luminal breast cancer, the exact mechanisms of how SLC1A5 expression contributes to endocrine resistance still require further mechanistic investigations. Here, SLC1A5 is linked to breast carcinoma.